Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Searching for smart, safe news you can TRUST?

Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Senate Majority Leader Mitch McConnell in the Capitol on Oct. 20. Photo: Stefani Reynolds/Getty Images

The Senate will vote to confirm Judge Amy Coney Barrett to the Supreme Court next Monday, Oct. 26, Majority Leader Mitch McConnell (R-Ky.) announced Tuesday.

The big picture: The Senate Judiciary Committee will vote this Thursday to advance Barrett's nomination to the full Senate floor. Democrats have acknowledged that there's nothing procedurally they can do to stop Barrett's confirmation, which will take place just one week out from Election Day.

Driving the news: The Supreme Court's 4-4 deadlock on a request from Pennsylvania's Republican Party to shorten the deadlines for mail-in ballots underscores the importance for conservatives of confirming Barrett before the election. President Trump himself has said Barrett could be a deciding vote in an election-related dispute.

What to watch: Joe Biden said at an ABC town hall last week that he will come out with a clear position on court packing by Nov. 3, but his answer will depend on how Barrett's confirmation is "handled."

Go deeper

Trump campaign loses yet another legal challenge in Pennsylvania

The president's lawyer Rudy Giuliani (center) has led legal efforts to cast doubt on election results, but few have succeeded. Photo: BRYAN R. SMITH/AFP via Getty

Philadelphia did not violate the law by restricting poll observers' proximity to ballots, the Pennsylvania Supreme Court ruled in a blow to the Trump campaign Tuesday.

Why it matters: This development comes after President Trump's defeat in a string of court battles, which his campaign wielded in several states in attempts to discredit President-elect Biden's election victory.

Judge tosses Trump campaign bid to block Pennsylvania vote certification

Election workers count ballots at the Philadelphia Convention Center Photo: Chris McGrath/Getty Images

A judge in Pennsylvania on Saturday dismissed a Trump campaign lawsuit that sought to invalidate millions of votes and block the certification of President-elect Joe Biden's victory in the state.

Why it matters: The ruling is another blow to President Trump and his campaign as they seek to discredit election tallies in Pennsylvania and other key swing states, citing baseless and unproven claims of widespread voter fraud. Counties in Pennsylvania must certify their election totals and send them to secretary of the commonwealth by Monday.

Updated 2 hours ago - Health

FDA authorizes emergency use of Regeneron antibody treatment given to Trump

The corporate and research and development headquarters of Regeneron Pharmaceuticals, Inc. in Tarrytown, N.Y. Photo: Lev Radin/Pacific Press/LightRocket via Getty Images


The Food and Drug Administration announced Saturday evening it has granted emergency use authorization for Regeneron Pharmaceuticals' antibody cocktail given to President Trump to treat his COVID-19 infection last month.

Why it matters: Regeneron's two monoclonal antibodies, casirivimab and imdevimab, are for people who tested positive for the coronavirus and "who are at high risk for progressing to severe COVID-19," including people who are 65 and older, and/or people with certain chronic illnesses, per an FDA statement.